Jounce Therapeutics Inc

NASDAQ:JNCE   3:59:52 PM EDT
5.25
-0.17 (-3.14%)
Products

Jounce Provides Update On Innate Study, Discovery Pipeline Expansion

Published: 06/23/2021 13:54 GMT
Jounce Therapeutics Inc (JNCE) - Jounce Therapeutics Provides Update on Innate Study and Discovery Pipeline Expansion, and Provides a Portfolio Update at 2021 Research and Development Day.
Jounce Therapeutics Inc - Introduction of Two Additional Lilrb Family Targets As Potential Development Candidates.
Jounce Therapeutics - Innate Clinical Trial Monotherapy and Pimivalimab Combination Expansion Cohort Initiation Expected in Q3 of 2021.